Tirzepatide 120mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist

Description

What is Tirzepatide?

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist — the first-in-class twincretin. Acts simultaneously on GIPR and GLP-1R to produce synergistic effects on insulin secretion, glucagon suppression, gastric emptying, and appetite suppression. Phase 3 (SURMOUNT-1): 20.9% mean weight loss at 72 weeks (15mg). The 120mg vial format provides high total peptide loading per kit for extended research protocols. Research use only.